Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al > Summary
Court Case Number 1:18-cv-01895
Filing Date Nov 29, 2018
Termination Date May 14, 2020
Court Delaware District Court
Status Dismissed - Settled
JudgesMaryellen Noreika
Plaintiff
Plaintiff Attorneys
6Duchesnay Inc.
Attorney Name: Benjamin T. Hemmelgarn
Finnegan, Henderson, Farabow, Garrett & Dunner
Duchesnay Inc.
Attorney Name: Cora R. Holt
Finnegan, Henderson, Farabow, Garrett & Dunner
Duchesnay Inc.
Attorney Name: Alexandra M. Joyce
McCarter & English
Duchesnay Inc.
Attorney Name: Barbara R. Rudolph
Finnegan, Henderson, Farabow, Garrett & Dunner
Duchesnay Inc.
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
13Actavis Laboratories FL
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Actavis Laboratories FL
Attorney Name: Karen E. Keller
Shaw Keller LLP
Actavis Laboratories FL
Attorney Name: Jessica K. Lam
Kirkland & Ellis
Actavis Laboratories FL
Attorney Name: Jay P. Lefkowitz
Kirkland & Ellis
Actavis Laboratories FL
Attorney Name: Ashley Ross
Kirkland & Ellis
Actavis Laboratories FL
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Jessica K. Lam
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Jay P. Lefkowitz
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Ashley Ross
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Actavis Laboratories FL
Attorney Name: Jean-Luc St-Onge
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09937132 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Apr 10, 2018 |
| 09526703 | Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Dec 27, 2016 |
| 09375404 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Jun 28, 2016 |
| 09089489 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Jul 28, 2015 |
